Home LiteratureArticle Details
PMID: 2369813 Published · ppublish English Comparative Study Journal Article

Economic impact of oral ciprofloxacin following standard intravenous therapy.

Diagnostic microbiology and infectious disease ·Vol. 13 ·No. 2 ·1990-00-00 ·Pages 187-9

Fliegelman RM, Mattingly PM, Dempsey CL, Sokalski SJ

Abstract

暂无摘要

MeSH Terms
Administration, Oral Adult Aged Aged, 80 and over Ciprofloxacin/administration & dosage,therapeutic use Costs and Cost Analysis Female Humans Injections, Intravenous Length of Stay/economics Male Middle Aged Random Allocation Respiratory Tract Infections/drug therapy
Chemicals
Ciprofloxacin
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Fliegelman R M
Section of Infectious Disease, Christ Hospital and Medical Center, Oak Lawn, Illinois 60453.
Mattingly P M
Dempsey C L
Sokalski S J
Article Info
Journal
Diagnostic microbiology and infectious disease
Abbr.
Diagn Microbiol Infect Dis
ISSN
0732-8893
DOI
10.1016/0732-8893(90)90107-7
Published
1990-00-00
Pages
187-9
Language
English
Region
United States
NLM ID
8305899
Subset
IM
External Links
PubMed source DOI: 10.1016/0732-8893(90)90107-7 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2